— Know what they know.
Not Investment Advice

NSCIF OTC

Nanalysis Scientific Corp.
1W: -18.5% 1M: -3.9% 3M: -5.2% YTD: -39.8% 1Y: -41.0% 3Y: -78.3% 5Y: -91.0%
$0.08
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Specialties · Tech Score Sell · Power 42 · $11.3M mcap · 133M float · 0.0074% daily turnover · Short 55% of daily vol

Income Trends

Revenue
$45M +59.8% ▲
5Y CAGR: +40.3%
Gross Profit
$13M +221.0% ▲
5Y CAGR: +16.0%
Operating Income
-$3M +70.4% ▲
Net Income
-$14M +18.9% ▲
EPS (Diluted)
$-0.12 +25.0% ▲
EBITDA
-$8M +13.4% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$8M$16M$25M$28M$45M
YoY Growth-5.9%+103.7%+54.7%+14.7%+59.8%
Cost of Revenue$3M$6M$14M$24M$33M
Gross Profit$5M$10M$10M$4M$13M
Gross Margin65.6%63.8%42.2%13.9%28.0%
R&D Expenses$476K$643K$1M$679K$544K
SG&A Expenses$7M$8M$14M$12M$11M
Operating Expenses$9M$11M$20M$16M$16M
Operating Income-$4M-$1M-$10M-$12M-$3M
Operating Margin-46.2%-7.4%-39.9%-40.8%-7.6%
Interest Expense$0$0$152K$284K$1M
Income Before Tax-$4M-$2M-$10M-$17M-$14M
Tax Expense-$297K$0-$484K-$11K-$22K
Net Income-$4M-$2M-$10M-$17M-$14M
Net Margin-46.7%-11.0%-39.9%-59.0%-29.9%
EPS (Diluted)$-0.06$-0.03$-0.11$-0.16$-0.12
EBITDA-$2M$1M-$5M-$9M-$8M
Shares Outstanding65M70M92M99M111M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms